Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PMV Pharmaceuticals, Inc. | Chief Financial Officer | Common Stock | 88.4K | $133K | $1.50 | Sep 11, 2024 | Direct |
PMV Pharmaceuticals, Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 205K | Jan 18, 2024 | Direct | ||
PMV Pharmaceuticals, Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 75K | Aug 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PMVP | PMV Pharmaceuticals, Inc. | Sep 11, 2024 | 1 | -$4.35K | 4 | Sep 12, 2024 | Chief Financial Officer |
PMVP | PMV Pharmaceuticals, Inc. | Aug 13, 2024 | 5 | $0 | 4 | Oct 3, 2024 | Chief Financial Officer |
PMVP | PMV Pharmaceuticals, Inc. | Jan 18, 2024 | 2 | $0 | 4 | Jan 22, 2024 | Chief Financial Officer |
PMVP | PMV Pharmaceuticals, Inc. | Jan 5, 2024 | 0 | $0 | 3 | Jan 11, 2024 | Chief Financial Officer |